biontech News of 11/28/20
Pfizer And BioNTech To Submit Request For Emergency Use Approval Of Their COVID-19 Vaccine Today
Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. ...
Pfizer Says Its COVID-19 Vaccine Is 95% Effective In Final Clinical Trial Results Analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. ...
Moderna Reports Its COVID-19 Vaccine Is 94.5% Effective In First Data From Phase 3 Trial
Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that its COVID-19 vaccine candidate has shown efficacy ...
Pfizer’S COVID-19 Vaccine Proves 90% Effective In First Results From Phase 3 Clinical Trial
The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announce d on Monday. That’s based on data analyzed ...